Botanix Pharma helps develop therapeutics for the treatment of serious skin diseases.

They work to improve the lives of patients by using a novel therapeutic and advanced transdermal drug delivery system, harnessing the potential of cannabidiol, a synthetic active pharmaceutical ingredient. They collaborate with a range of partners for the supply of synthetic CBD, the manufacturing of GMP material in a DEA licensed facility for clinical trials, and the conduct of well controlled human clinical trials. They work with experienced DEA and FDA advisors to remain compliant with specific licensing and product handling legal requirements.

Botanix Pharma has products focused on the safe and effective topical treatment of serious skin diseases like dermatitis, psoriasis, severe acne and eczema.

Their Permetrex™ technology, a novel transdermal drug delivery method does not utilise drying chemicals in delivering pharmaceuticals through the skin, which makes it an ideal alternative for diseases such as acne and psoriasis. It facilitates rapid delivery of medication by creating substantial kinetic energy when applied to the skin, and it can accommodate other chemicals used to leave parts of the medication on the skin in the form of a protective coating that promotes absorption.

Botanix Pharma uses Permetrex™ to bypass the digestive system and liver metabolism, which allows for rapid and reliable absorption of the medication dose without wastage. Absorption of the drug is safer and more efficient. They are working with pharmaceutical partners to integrate the Permetrex delivery system into proprietary active formulation of better, more effective drugs.

For general enquiries, Botanix Pharma can be contacted by emailing [email protected] or by calling 61 8 6555 2945. Their registered office is located at Level 1, 50 Angove Street, North Perth WA 6006, and they can be sent correspondence at PO Box 1407, Subiaco WA 6904.